Halo gradient banner.jpg
 
HALO logo with blue lettering and yellow line above the O.
 
 

Heparin Anticoagulation to improve Outcomes in septic shock: The HALO International Phase II RCT

Patient lying in bed surrounded by machines

Number of Patients Enrolled: 163

as of May 2021

Doctor writing in chart

Number of Sites Participating: 42

as of May 2020

Patient lying in bed with monitor showing

HALO Randomization

Click Here

 Funders

Partners & Collaborators

 Trial Site Locations

Click on the map to view information about our Trial Site Locations.

Click here for Principal Investigator and Research Coordinator information for each site.

Contact